FDA approves Eli Lilly’s Cyramza for lung cancer

Eli Lilly gained Cyramza when it acquired ImClone in 2008.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.